These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30653927)

  • 41. Validation of Proposed Criteria for Progressive Pulmonary Fibrosis.
    Pugashetti JV; Adegunsoye A; Wu Z; Lee CT; Srikrishnan A; Ghodrati S; Vo V; Renzoni EA; Wells AU; Garcia CK; Chua F; Newton CA; Molyneaux PL; Oldham JM
    Am J Respir Crit Care Med; 2023 Jan; 207(1):69-76. PubMed ID: 35943866
    [No Abstract]   [Full Text] [Related]  

  • 42. Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging.
    Chung JH; Adegunsoye A; Cannon B; Vij R; Oldham JM; King C; Montner SM; Thirkateh P; Barnett S; Karwoski R; Bartholmai BJ; Strek M; Nathan SD
    J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34204184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute exacerbations of fibrotic interstitial lung diseases.
    Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
    Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between nailfold capillaroscopy findings and the etiology and prognosis of interstitial lung disease.
    Acemoğlu ŞŞZ; Türk İ; Deniz PP; Aşık MA; Arslan D; Hanta İ; Ünal İ
    Clin Rheumatol; 2024 Aug; 43(8):2679-2687. PubMed ID: 38963466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients With Interstitial Lung Disease.
    Cutting CC; Bowman WS; Dao N; Pugashetti JV; Garcia CK; Oldham JM; Newton CA
    Chest; 2021 May; 159(5):1913-1921. PubMed ID: 33484728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usefulness of Transbronchial Lung Cryobiopsy When Starting Antifibrotic Treatment and Predicting Progressive Fibrosing Interstitial Lung Disease: Descriptive Research.
    Takatsuka M; Yamakawa H; Takemura T; Sato S; Ohta H; Kusano K; Oba T; Kawabe R; Akasaka K; Sasaki H; Amano M; Araya J; Matsushima H
    Clin Respir J; 2024 Jul; 18(7):e13809. PubMed ID: 39013830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.
    Torrisi SE; Kahn N; Wälscher J; Sarmand N; Polke M; Lars K; Eichinger M; Heussel CP; Palmucci S; Sambataro FM; Sambataro G; Sambataro D; Vancheri C; Kreuter M
    BMC Pulm Med; 2019 Nov; 19(1):213. PubMed ID: 31718637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Computed Tomography-Based Deep Learning Model for Assessing the Severity of Patients With Connective Tissue Disease-Associated Interstitial Lung Disease.
    Su N; Hou F; Zheng W; Wu Z; E L
    J Comput Assist Tomogr; 2023 Sep-Oct 01; 47(5):738-745. PubMed ID: 37707403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease.
    Nishiyama N; Masuo M; Nukui Y; Tateishi T; Kishino M; Tateishi U; Morota K; Ohbo K; Miyazaki Y
    Respir Investig; 2021 Jan; 59(1):90-98. PubMed ID: 32919933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
    Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
    BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype.
    Takei R; Brown KK; Yamano Y; Kataoka K; Yokoyama T; Matsuda T; Kimura T; Suzuki A; Furukawa T; Fukuoka J; Johkoh T; Goto Y; Kondoh Y
    Respirology; 2022 May; 27(5):333-340. PubMed ID: 35293077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of progressive pulmonary fibrosis in non-idiopathic pulmonary fibrosis-interstitial lung diseases: a cross-sectional study.
    Erçen Diken Ö; Güngör Ö; Akkaya H
    BMC Pulm Med; 2024 Aug; 24(1):403. PubMed ID: 39169372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of radiographic honeycombing on transplant free survival and efficacy of immunosuppression in fibrotic hypersensitivity pneumonitis.
    Adams TN; Batra K; Kypreos M; Glazer CS
    BMC Pulm Med; 2023 Jun; 23(1):224. PubMed ID: 37349780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical relevance of rheumatoid factor and anti-citrullinated peptides in fibrotic interstitial lung disease.
    Zheng B; Donohoe K; Hambly N; Johannson KA; Assayag D; Fisher JH; Manganas H; Marcoux V; Khalil N; Kolb M; Ryerson CJ;
    Respirology; 2022 Oct; 27(10):854-862. PubMed ID: 35652240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
    Tyker A; Ventura IB; Lee CT; Strykowski R; Garcia N; Guzy R; Jablonski R; Vij R; Strek ME; Chung JH; Adegunsoye A
    Sci Rep; 2021 Nov; 11(1):22821. PubMed ID: 34819525
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung Disease: A Multicenter Study.
    Khor YH; Farooqi M; Hambly N; Johannson KA; Marcoux V; Fisher JH; Assayag D; Manganas H; Khalil N; Kolb M; Ryerson CJ;
    Chest; 2023 Feb; 163(2):345-357. PubMed ID: 36089070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs).
    Spagnolo P; Distler O; Ryerson CJ; Tzouvelekis A; Lee JS; Bonella F; Bouros D; Hoffmann-Vold AM; Crestani B; Matteson EL
    Ann Rheum Dis; 2021 Feb; 80(2):143-150. PubMed ID: 33037004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of radiological honeycombing in rheumatoid arthritis-associated interstitial lung disease.
    Yamakawa H; Sato S; Nishizawa T; Kawabe R; Oba T; Kato A; Horikoshi M; Akasaka K; Amano M; Sasaki H; Kuwano K; Matsushima H
    BMC Pulm Med; 2020 Jan; 20(1):25. PubMed ID: 32000736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
    Singh P; Thakur B; Mohapatra AK; Padhan P
    Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease.
    Khor YH; Johannson KA; Marcoux V; Fisher JH; Assayag D; Manganas H; Khalil N; Kolb M; Ryerson CJ;
    Am J Respir Crit Care Med; 2024 Oct; 210(8):1035-1044. PubMed ID: 38536110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.